CSI Market
Sign In | Register

Five Prime Therapeutics Inc (FPRX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access FPRX Annual Cash Flow →
Cash flow data covering Five Prime Therapeutics Inc–Dec 31 2019 offers a view into how Dec 31 2020's cash position has developed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2020)
12 Months 		(Sep 30 2020) (Jun 30 2020) (Mar 31 2020) (Dec 31 2019)
Operating Activities
Income-84.33
Depreciation & amortization3.20
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Other Asset Impairment Charges0.39
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment-3.62
Share-based Compensation10.19
Income (Loss) from Equity Method Investments0.00
Increase (Decrease) in Restricted Cash for Operating Activities0.00
Re Measurement Of Preferred Stock Warrant Liability-
Increase Decrease In Receivable From Collaboration Partners2.61
Increase Decrease In Payable To Collaborative Partner-
Increase Decrease In Deferred Rent-
Non Cash Operating Lease Expense1.89
Impairment Of R O U Assets8.79
Tangible Asset Impairment Charges-3.31
Operating Lease R O U Asset Amortization Expense-
Increase Decrease In Operating Lease Liabilities-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Employee Related Liabilities-1.60
Increase (Decrease) in Accounts Payable-0.69
Increase (Decrease) in Other Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-1.70
Other Working Capital1.70
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities4.39
Discontinued operations0.00
Net Cash flow from Operating Activities-64.65
Investing Activities
Capital Expenditures-0.06
Sale of Capital Items6.74
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities169.02
Payments to Acquire Marketable Securities-286.33
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-110.63
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock167.39
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-52.56
Proceeds From Deferred Offering Cost-
Reversal Of Excess Tax Benefit Associated With Share Based Compensation Due To Net Operating Loss Carryback-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Capital Expenditures Incurred But Not Yet Paid-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations57.34
Proceeds From Disgorgement Of Stockholder Short Swing Profits-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities188.91
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-57.97
Total Cash Flow13.62
4 historic quarters locked

Sign in to unlock the full Five Prime Therapeutics Inc cash flow history.

Sign In Create Free Account

About FPRX Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.